3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
7
Carcinoma, Renal Cell
4
Triple Negative Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Small Cell Lung Carcinoma
3
Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Advanced Solid Tumor
3
Stomach Neoplasms
2
Neoplasm Metastasis
2
Nasopharyngeal Neoplasms
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Advanced Breast Cancer
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Turcot syndrome
1
Solid Tumor
1
Skin Neoplasms
1
Sarcoma
1
Recurrence
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Pancreatic Cancer Metastatic
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
NSCLC
1
Muscle Invasive Bladder Cancer (MIBC)
1
Interventions
pembrolizumab
52
Paclitaxel
19
Cisplatin
14
Carboplatin
14
lenvatinib
10
Docetaxel
8
Saline Solution
7
Capecitabine
7
Pemetrexed
6
Oxaliplatin
6
Gemcitabine
6
Fluorouracil
6
Leucovorin
5
Albumin-Bound Paclitaxel
5
olaparib
4
belzutifan
4
Bevacizumab
4
130-nm albumin-bound paclitaxel
4
patritumab deruxtecan
3
Glucose
3
Acetaminophen
3
liposomal doxorubicin
2
Levoleucovorin
2
Irinotecan
2
Histamine H2 Antagonists
2
Histamine Antagonists
2
Etoposide
2
Doxorubicin
2
Dexamethasone
2
Cetuximab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
toripalimab
×
90 days
×
Clear all
No trials found.